$179 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 43 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 63.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | $25,052,000 | -11.0% | 554,000 | 0.0% | 13.96% | +6.1% | |
| AADI BIOSCIENCES INC | $18,842,000 | -27.4% | 1,529,402 | 0.0% | 10.50% | -13.4% | ||
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $9,998,000 | -31.3% | 11,361,451 | -3.2% | 5.57% | -18.1% |
| KURA | Buy | KURA ONCOLOGY INC. COMMON STOCK | $9,834,000 | +29.0% | 536,500 | +13.2% | 5.48% | +53.9% |
| BLSA | BCLS ACQUISITION CORP- CL A | $8,347,000 | +0.3% | 843,122 | 0.0% | 4.65% | +19.6% | |
| XENE | Buy | XENON PHARMACEUTICALS INC | $8,289,000 | +20.5% | 272,500 | +21.1% | 4.62% | +43.7% |
| BLU | BELLUS HEALTH INC | $7,540,000 | +34.3% | 816,000 | 0.0% | 4.20% | +60.2% | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC | $7,204,000 | -34.5% | 267,195 | -17.3% | 4.01% | -21.9% |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $6,694,000 | -27.5% | 352,500 | +3.1% | 3.73% | -13.5% |
| MRTX | Buy | MIRATI THERAPEUTICS | $6,344,000 | +47.0% | 94,500 | +80.0% | 3.53% | +75.2% |
| JYAC | JIYA ACQUISITION CORP -CL A | $5,552,000 | +0.5% | 562,500 | 0.0% | 3.09% | +19.8% | |
| ISEE | Buy | IVERIC BIO INC | $5,422,000 | -40.3% | 563,607 | +4.5% | 3.02% | -28.8% |
| New | ROCHE GS | $5,338,000 | – | 16,000 | +100.0% | 2.97% | – | |
| RCUS | New | ARCUS BIOSCIENCES INC | $4,244,000 | – | 167,500 | +100.0% | 2.36% | – |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $3,944,000 | +10.1% | 205,003 | -0.5% | 2.20% | +31.2% |
| HSAQ | HEALTH SCIENCES ACQUISITIONS | $3,909,000 | +0.5% | 392,500 | 0.0% | 2.18% | +19.8% | |
| MRUS | Sell | MERUS BV | $3,487,000 | -44.0% | 154,000 | -34.6% | 1.94% | -33.2% |
| DTIL | New | PRECISION BIOSCIENCES INC | $3,281,000 | – | 2,050,359 | +100.0% | 1.83% | – |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $3,063,000 | – | 13,000 | +100.0% | 1.71% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PLC | $2,862,000 | -18.1% | 35,888 | +8.1% | 1.59% | -2.3% |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $2,812,000 | +15.2% | 457,200 | +20.3% | 1.57% | +37.5% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $2,708,000 | -56.9% | 234,026 | -31.2% | 1.51% | -48.6% |
| ACRS | Sell | ACLARIS THERAPEU | $2,692,000 | -28.2% | 192,835 | -11.4% | 1.50% | -14.4% |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $2,428,000 | -68.4% | 243,250 | -42.0% | 1.35% | -62.3% |
| EYPT | Sell | EYEPOINT PHARMACEUTICALS INC | $2,388,000 | -36.2% | 303,396 | -1.5% | 1.33% | -23.9% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS INC | $2,180,000 | -42.5% | 61,926 | -24.9% | 1.21% | -31.5% |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $2,173,000 | -23.0% | 152,500 | +12.5% | 1.21% | -8.1% |
| RZLT | New | REZOLUTE INC | $2,084,000 | – | 645,136 | +100.0% | 1.16% | – |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $1,704,000 | -13.9% | 154,356 | +29.9% | 0.95% | +2.6% |
| Buy | PYXIS ONCOLOGY INC | $1,535,000 | +90.0% | 645,149 | +222.6% | 0.86% | +126.2% | |
| Buy | VENTYX BIOSCIENCES INC | $1,492,000 | +55.1% | 122,000 | +72.1% | 0.83% | +85.1% | |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $1,300,000 | +692.7% | 27,500 | +1095.7% | 0.72% | +840.3% |
| ITOS | New | ITEOS THERAPEUTICS INC | $1,277,000 | – | 62,000 | +100.0% | 0.71% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $1,007,000 | – | 71,500 | +100.0% | 0.56% | – |
| FULC | FULCRUM THERAPEUTICS INC | $980,000 | -79.3% | 200,000 | 0.0% | 0.55% | -75.3% | |
| New | AC IMMUNE SAcall | $354,000 | – | 100,000 | +100.0% | 0.20% | – | |
| New | ATHIRA PHARMA INCcall | $340,000 | – | 100,000 | +100.0% | 0.19% | – | |
| GOSS | New | GOSSAMER BIO INC | $268,000 | – | 32,000 | +100.0% | 0.15% | – |
| VSTM | Sell | VERASTEM INC | $232,000 | -83.5% | 200,000 | -79.9% | 0.13% | -80.4% |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $123,000 | – | 5,000 | +100.0% | 0.07% | – |
| TRVI | New | TREVI THERAPEUTICS INC | $98,000 | – | 35,000 | +100.0% | 0.06% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $53,000 | – | 13,171 | +100.0% | 0.03% | – |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $25,000 | – | 90,832 | +100.0% | 0.01% | – |
| NUVB | Exit | NUVATION WARRANTS*w exp 07/07/202 | $0 | – | -90,832 | -100.0% | -0.03% | – |
| SEEL | Exit | SEELOS THERAPEUTICS INC | $0 | – | -295,896 | -100.0% | -0.12% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -55,000 | -100.0% | -0.12% | – |
| ACIU | Exit | CALL- ACIU 100@7 1/2EXP 08/19/2022call | $0 | – | -100,000 | -100.0% | -0.19% | – |
| Exit | DICE THERAPEUTICS INC | $0 | – | -37,500 | -100.0% | -0.34% | – | |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -307,125 | -100.0% | -0.50% | – |
| ATHA | Exit | CALL- ATHA 100@12 1/2 EXP 07/15/2022call | $0 | – | -100,000 | -100.0% | -0.63% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -140,030 | -100.0% | -0.88% | – |
| PMVP | Exit | CALL- PMVP 100 @ 20 EXP 06/17/2022call | $0 | – | -100,000 | -100.0% | -0.97% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -497,500 | -100.0% | -1.16% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -580,000 | -100.0% | -1.85% | – |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -813,500 | -100.0% | -2.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.